Alginate encapsulated human mesenchymal stem cells suppress syngeneic glioma growth in the immunocompetent rat

References

• Albesiano E, Han JE, Lim M. Mechanisms of local immunoresistance in glioma. Neurosurg Clin N Am 2010; 21: 17–29
   PubMed Web of Science ®Google Scholar
• Bjerkvig R, Read TA, Vajkoczy P, Aebischer P, Pralong W, Platt S, Melvik JE, Hagen A, Dornish M. Cell therapy using encapsulated cells producing endostatin. Acta Neurochir Suppl 2003; 88: 137–41
   PubMedGoogle Scholar
• Borlongan CV. Cell therapy for stroke: Remaining issues to address before embarking on clinical trials. Stroke 2009; 40: S146–8
   PubMed Web of Science ®Google Scholar
• Druckrey H, Schagen B, Ivankovic S. [Induction of neurogenic malignancies by one single dose of ethyl-nitrosourea (ENU) given to newborn and juvenile BD IX-strain rats] Erzeugung neurogener Malignome durch einmalige Gabe von Athyl-nitrosoharnstoff (ANH) an neugeborene und junge BD IX-Ratten. Z Krebsforsch, 1970;74:141–61
   Google Scholar
• Fernando NT, Koch M, Rothrock C, Gollogly LK, D’Amore PA, Ryeom S, Yoon SS. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors. Clin Cancer Res 2008; 14: 1529–39
   PubMed Web of Science ®Google Scholar
• Goren A, Dahan N, Goren E, Baruch L, Machluf M. Encapsulated human mesenchymal stem cells: A unique hypoimmunogenic platform for long-term cellular therapy. FASEBJ 2010; 24: 22–31
   PubMed Web of Science ®Google Scholar
• Heile AM, Wallrapp C, Klinge PM, Samii A, Kassem M, Silverberg G, Brinker T. Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. Neurosci Lett 2009; 463: 176–81
   PubMed Web of Science ®Google Scholar
• Huang G, Chen L. Discrepancies between antiangiogenic and antitumor effects of recombinant human endostatin. Cancer Biother Radiopharm 2009; 24: 589–96
   PubMed Web of Science ®Google Scholar
• Joki T, Machluf M, Atala A, Zhu J, Seyfried NT, Dunn IF, Abe T, Carroll RS, Black PM. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 2001; 19: 35–9
   PubMed Web of Science ®Google Scholar
• Klinge PM, Harmening K, Miller MC, Heile A, Wallrapp C, Geigle P, Brinker T. Encapsulated native and Glucagon-like peptide-1 transfected human mesenchymal stem cells in a transgenic mice model of Alzheimer's disease. Neurosci Lett 2011; 497(1): 6–10
   Web of Science ®Google Scholar
• Kucerova L, Matuskova M, Hlubinova K, Altanerova V, Altaner C. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 2010; 9: 129
   PubMed Web of Science ®Google Scholar
• Lindvall O, Wahlberg LU. Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?. Exp Neurol 2008; 209: 82–8
   PubMed Web of Science ®Google Scholar
• Momin EN, Vela G, Zaidi HA. Quinones-Hinojosa A. The oncogenic potential of mesenchymal stem cells in the treatment of cancer: Directions for future research. Curr Immunol Rev 2010; 6: 137–48
   PubMedGoogle Scholar
• Motaln H, Schichor C, Lah TT. Human mesenchymal stem cells and their use in cell-based therapies. Cancer 2010; 116: 2519–30
   PubMed Web of Science ®Google Scholar
• Murua A, Portero A, Orive G, Hernandez RM, de Castro M, Pedraz JL. Cell microencapsulation technology: Towards clinical application. J Control Release 2008; 132: 76–83
   PubMed Web of Science ®Google Scholar
• Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65: 3307–18
   PubMed Web of Science ®Google Scholar
• Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y, Hamada H. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11: 1155–64
   PubMed Web of Science ®Google Scholar
• O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277–85
   PubMed Web of Science ®Google Scholar
• Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, Inoue M, Bergers G, Hanahan D, Casanovas O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009; 15: 220–31
   PubMed Web of Science ®Google Scholar
• Pradilla G, Legnani FG, Petrangolini G, Francescato P, Chillemi F, Tyler BM, Gaini SM, Brem H, Olivi A, DiMeco F. Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas. Neurosurgery 2005; 57: 1032–40
   PubMed Web of Science ®Google Scholar
• Read TA, Sorensen DR, Mahesparan R, Enger PO, Timpl R, Olsen BR, Hjelstuen MH, Haraldseth O, Bjerkvig R. Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat Biotechnol 2001; 19: 29–34
   PubMed Web of Science ®Google Scholar
• Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, Jensen T G, Kassem M. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002; 20: 592–6
   PubMed Web of Science ®Google Scholar
• Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, et al. From the cover: Feature article: Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA 2011; 108: 4274–80
   PubMed Web of Science ®Google Scholar
• Stagg J. Mesenchymal stem cells in cancer. Stem Cell Rev 2008; 4: 119–24
   PubMed Web of Science ®Google Scholar
• Sughrue ME, Yang I, Kane AJ, Rutkowski MJ, Fang S, James CD, Parsa AT. Immunological considerations of modern animal models of malignant primary brain tumors. J Transl Med 2009; 7: 84
   PubMed Web of Science ®Google Scholar
• Weiner NE, Pyles RB, Chalk CL, Balko MG, Miller MA, Dyer CA, Warnick RE, Parysek LM. A syngeneic mouse glioma model for study of glioblastoma therapy. J Neuropathol Exp Neurol 1999; 58: 54–60
   PubMed Web of Science ®Google Scholar
• Yang SY, Liu H, Zhang JN. Gene therapy of rat malignant gliomas using neural stem cells expressing IL-12. DNA Cell Biol 2004; 23: 381–9
   PubMed Web of Science ®Google Scholar
• Yu JM, Jun ES, Bae YC, Jung JS. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev 2008; 17: 463–73
   PubMed Web of Science ®Google Scholar
• Zimmermann U, Thurmer F, Jork A, Weber M, Mimietz S, Hillgartner M, Brunnenmeier F, Zimmermann H, Westphal I, Fuhr G, et al. A novel class of amitogenic alginate microcapsules for long-term immunoisolated transplantation. Ann NY Acad Sci 2001; 944: 199–215
   PubMed Web of Science ®Google Scholar